Postponed to 2021, Global BSG, Zurich, 2nd Annual Pharma AI Summit
Oct 2020, Virtual, AI Application in BioPharma Summit
Mar 2020, Mol-Tri-Med, San Francisco.AI and Rare Diseases Treatment
Mar 2020, Mol Tri-Med, San Francisco. Partnering for AI Startups and Pharma
Jan 2020, West Coast Australian American Leadership Dialogue, San Francisco and Los Angeles. Data analytics, healthcare, challenges, use cases, and business models
Nov 2019, Washington DC, USA: AI Enabled IND and NDA Workshop – Drug Development Series v1.0.
June 2019, Washington DC, USA: AI
World Government. AI and Healthcare.
a) AAIH Primer in Healthcare,
b) How industry is using AI in Healthcare,
c) How Federal Agencies are Advancing Public Private Partnerships.
May 2019, Shanghai, China: Asia Pharma R&D Leaders’ Summit 2019, AI Innovation in Pharma: “Strengthening Global Collaboration and Partnership for AI in Healthcare”.
Apr 2019, Toronto, Canada: Health Innovation Week Invest. "AI and Big Data - Therapeutics Investing".
Nov 2018, Seoul, Korea: Tv Chosun 6th Global Leaders Forum 2018, “The invisible is Changing the world: The Bio Revolution, the dream of immortality”.
Mar 2016, Nice, France: SEMI ISS Europe Reaching into a New Era: “Transforming Markets, New Applications, New opportunities for Nanoelectronics for Healthcare”
June 2014, Brussels, Belgium: IMEC Technology Forum 2014: “Generic silicon nanotechnologies for truly personalized healthcare”
April 2014, Turin, Italy: Bio-Europe Partnering: “Partnering with provider institutions: The new healthcare model?”
AI in Healthcare: A Technical Primer. 2019.
Engineering a Prostate-Specific Membrane Antigen (PSMA) activated tumor endothelial cell prodrug for cancer therapy. Sci Transl Med
Applying Linear Interaction Energy Method for Rational Design of Non-competitive Allosteric Inhibitors of the SERCA pump. Journal of Medicinal Chemistry
Use of Methotrexate-Based Peptide Substrates to Characterize the Substrate Specificity of Prostate Membrane Specific Antigen (PSMA)
Prostate-Specific Membrane Antigen (PSMA) targeted prodrug "smartbombs" as therapy for prostate cancer. Proc Amer Assoc Cancer Res
Enzymatic Activation of Prodrugs by Prostate Specific Membrane Antigen (PSMA). European J Cancer
Synthesis and Biological Evaluation of Novel Prostate Specific Antigen (PSA) Specific Peptide Prodrugs for Prostate Cancer. Clin Cancer Research
A 5-fluorodeoxyuridine Prodrug as Targeted Therapy for Prostate Cancer. Bioorg Med Chem Lett.
Modified Synthesis and Antiangiogenic Activity of Linomide. Bioorg Med Chem Lett.
Dynamics of Molecular Penning Ionization: Angle Energy Distributions of N2+ from He* (21S) + N2. Chem. Phys Lett.
Mawambo LLC
100 International Dr. Fl. 23
Baltimore MD 21202
Copyright © 2020 Mawambo - All Rights Reserved.